Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
about
Poxviruses and the evolution of host range and virulenceOrthopox Viruses: Infections in HumansRapid and high-throughput pan-Orthopoxvirus detection and identification using PCR and mass spectrometryExperimental infection of cynomolgus macaques (Macaca fascicularis) with aerosolized monkeypox virus.Protective properties of vaccinia virus-based vaccines: skin scarification promotes a nonspecific immune response that protects against orthopoxvirus disease.Use of the Aerosol Rabbitpox Virus Model for Evaluation of Anti-Poxvirus Agents.Efficacy of CMX001 as a prophylactic and presymptomatic antiviral agent in New Zealand white rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humansEfficacy of CMX001 as a post exposure antiviral in New Zealand White rabbits infected with rabbitpox virus, a model for orthopoxvirus infections of humansSmallpox vaccines: targets of protective immunity.Development of CMX001 for the Treatment of Poxvirus Infections.Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges.Synthesis and early development of hexadecyloxypropylcidofovir: an oral antipoxvirus nucleoside phosphonate.Ectromelia virus infections of mice as a model to support the licensure of anti-orthopoxvirus therapeutics.Genetic diversity comparison of the DQA gene in European rabbit (Oryctolagus cuniculus) populations.Bioluminescent imaging of vaccinia virus infection in immunocompetent and immunodeficient rats as a model for human smallpoxUpdate on new antivirals under development for the treatment of double-stranded DNA virus infectionsEvaluation of inhaled cidofovir as postexposure prophylactic in an aerosol rabbitpox model.Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.Isolation and characterization of cidofovir resistant vaccinia viruses.Orthopoxvirus targets for the development of new antiviral agents.Progress in the discovery of compounds inhibiting orthopoxviruses in animal models.Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.Alkoxyalkyl prodrugs of acyclic nucleoside phosphonates enhance oral antiviral activity and reduce toxicity: current state of the art.Generating aptamers for recognition of virus-infected cells.Animal models of orthopoxvirus infection.Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus.Myxoma virus expressing interleukin-15 fails to cause lethal myxomatosis in European rabbits.The Role of Brincidofovir in Preparation for a Potential Smallpox Outbreak.Challenges and Achievements in Prevention and Treatment of Smallpox.Oral Tecovirimat for the Treatment of SmallpoxRabbitpox in New Zealand White Rabbits: A Therapeutic Model for Evaluation of Poxvirus Medical Countermeasures Under the FDA Animal Rule
P2860
Q28658130-685EF697-6B1F-455B-9742-152DE584628BQ28742218-9EB8AAA7-FF95-4FDA-BE2E-A368F0A1F4F9Q28752270-C3B03089-FB55-4380-B0E3-4BE5CC47A099Q33700318-CB697F1D-3F3A-44D1-BB02-DB51CAE92285Q33900244-61003D0F-C1C3-47C8-A965-365283CC831FQ34196187-5A18C28A-309D-4271-B7B2-5D330E064337Q34611138-CAF88415-4C61-4667-9E1D-F565BDE74DB1Q34615572-90C10555-206C-494A-8E9E-22B5182408BBQ34780607-4871F3F0-48B1-4ED4-BE86-4188F5F90B4FQ34801704-7DCE80BE-85CD-4EE7-BFBB-7713E2B0DCF8Q35140284-50342D82-7E62-4BF6-9169-7721D8CF4C4BQ35260316-E2D1D13B-236A-4297-AAB1-23DD763B207BQ35261304-2D6E5197-B267-4587-BDB8-D0D24B9CEB40Q35755455-1B947FD6-2714-454E-9C7F-600B74FCCEE7Q35909727-01B9DDC2-3ED3-4BE8-B2F4-92F14CCFC4E3Q36185647-4E90C18D-4123-4F3D-9657-F129486E1B0FQ36422006-B05A7A16-D307-49CB-A7DE-1292591CED94Q36559636-52A6D57D-A643-4A6E-ACB7-D752E478D099Q36678276-FFCDDCE2-17A0-4759-83E4-D7B7E46CC465Q37173398-D7FD4A19-A106-4C6F-B5AF-5EBE5988EB32Q37331541-48C06016-EE8D-4674-B5B2-5FDAA9EF4F0DQ37332861-BAEC66A0-3C8E-4A1C-AF6F-CDF81B243717Q37401749-0E157C36-2F69-4D7D-980B-9D88C475A3C1Q37407770-A731B936-5A6B-4889-A387-D53E772AD16EQ37777545-D8386238-ED17-4257-B044-9C45854F0DD6Q37791160-C01F29D5-AE03-4261-8BF3-A3022CFE175BQ38665106-2D320661-2209-439F-896C-1C13E3A1065EQ39995833-4BDC97BC-B858-40C5-963D-086D91274EDCQ47162853-C6D8E189-2E53-4EF5-BFEC-1117E5A7DB6CQ47547852-22ACDBD6-A5F5-493A-8A80-EE07C86E129AQ55882584-70F710D4-AE73-4908-A13D-CB209C9B50C0Q57817902-E35D5A60-2EC1-43A8-B5DB-DF25D9ACBDC0
P2860
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
@ast
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
@en
type
label
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
@ast
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
@en
prefLabel
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
@ast
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
@en
P2093
P2860
P356
P1433
P1476
Rabbitpox virus and vaccinia virus infection of rabbits as a model for human smallpox
@en
P2093
Amanda D Rice
Mathew M Adams
P2860
P304
11084-11095
P356
10.1128/JVI.00423-07
P407
P577
2007-08-08T00:00:00Z